Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -16.8 Million USD | 50.39% |
| 2022 | -35.8 Million USD | 25.94% |
| 2021 | -35.19 Million USD | -40.4% |
| 2020 | -23.25 Million USD | 30.58% |
| 2019 | -41.72 Million USD | -570.45% |
| 2018 | -5.3 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -2.52 Million USD | 27.91% |
| 2023 Q1 | -3.5 Million USD | 30.16% |
| 2023 Q3 | -6.98 Million USD | -176.04% |
| 2023 Q4 | -4.48 Million USD | 35.83% |
| 2023 FY | - USD | 50.39% |
| 2022 Q4 | -5.02 Million USD | -133.34% |
| 2022 Q3 | 15.06 Million USD | 448.62% |
| 2022 FY | - USD | 25.94% |
| 2022 Q2 | -4.32 Million USD | 37.7% |
| 2022 Q1 | -6.93 Million USD | 27.54% |
| 2021 FY | - USD | -40.4% |
| 2021 Q4 | -9.57 Million USD | 6.25% |
| 2021 Q3 | -10.21 Million USD | -19.61% |
| 2021 Q2 | -8.53 Million USD | -33.98% |
| 2021 Q1 | -6.37 Million USD | 0.5% |
| 2020 Q4 | -6.4 Million USD | -54.03% |
| 2020 Q3 | -4.15 Million USD | 41.16% |
| 2020 Q2 | -7.06 Million USD | 0.25% |
| 2020 Q1 | -7.08 Million USD | 57.21% |
| 2020 FY | - USD | 30.58% |
| 2019 Q1 | -4.2 Million USD | 0.0% |
| 2019 FY | - USD | -570.45% |
| 2019 Q3 | -8.68 Million USD | -73.82% |
| 2019 Q4 | -16.55 Million USD | -90.57% |
| 2019 Q2 | -4.99 Million USD | -18.72% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bright Green Corporation | - USD | Infinity% |
| BioQuest Corp. | -33.57 USD | -50056498.153% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 121.682% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | -328.416% |
| GSRX Industries Inc. | - USD | Infinity% |
| High Sierra Technologies, Inc. | -181.97 Thousand USD | -9134.438% |
| Instadose Pharma Corp. | - USD | Infinity% |